ALNOV:EPA
Novacyt SA
0,46 €
arrow_downward
-0,11%(-0,00050) 1D
21 tet, 10:45:00 p.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALNOV...
Hap
0,46 €
I lartë
0,46 €
I ulët
0,46 €
Kapitalizimi i tregut
33,56 mln
Vëllimi mesatar
235,63 mijë
Vëllimi
6,19 mijë
Maksimumi 52-javor
1,04 €
Minimumi 52-javor
0,29 €
Fitimet për aksion
-0,37 €
Aksionet në qarkullim
72,59 mln
Numri i punonjësve
228
Hap
0,46 €
I lartë
0,46 €
I ulët
0,46 €
Kapitalizimi i tregut
33,56 mln
Vëllimi mesatar
235,63 mijë
Vëllimi
6,19 mijë
Maksimumi 52-javor
1,04 €
Minimumi 52-javor
0,29 €
Fitimet për aksion
-0,37 €
Aksionet në qarkullim
72,59 mln
Numri i punonjësve
228
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Black Hills Pioneer
·
16 minuta më parë
DataMeds Regains Compliance With NASDAQ Listing Standards
Moomoo
·
11 minuta më parë
Dow Jones Top Company Headlines at 5 AM ET: Tesla and SpaceX Formed Committees to Discuss Potential Merger, Elon Musk Says | Netflix ...
The Motley Fool
·
23 minuta më parë
2 Nasdaq-100 Stocks to Buy Before They Soar 105% and 130%, According to Wall Street
Yahoo Finance
·
35 minuta më parë
Nasdaq Futures Rise Premarket As SpaceX AI Boom Lifts Chip Stocks: SMCI, TSLA, META, IBM, CRWV, NFLX, BE In Focus
Profili
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Rreth Novacyt SA
Drejtori ekzekutivDavid Allmond
Punonjësit228
Themeluar më3 korr 2006
Selia-
Sektori-
Uebsajtinovacyt.com